[Prescription of high-cost medicines in French Hospitals: Regulation and procedures of reimbursement]. / Modalités de prescription hospitalières des molécules onéreuses : cadre réglementaire global et spécificités de la prescription hors GHS.

The high cost of several drugs or medical devices involves specific reimbursement procedures in French hospitals. Specific prescription rules have been developed and a regular survey by regional health authorities is performed. These particular funding procedures allow patients to access to innovative drugs. Some questions have recently been raised in France about the list of cancer drugs that could be concerned by an additional funding by health insurance. In this setting, this article proposes to summarize the current modalities of reimbursement of high-cost medicines in French Hospitals to enlighten the current debate.